Department of Endocrinology, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang, 330002, P. R. China.
Faculty of Thai Traditional Medicine, Prince of Songkla University, Hat Yai, 90110, Thailand.
Chem Biodivers. 2020 Mar;17(3):e1900661. doi: 10.1002/cbdv.201900661. Epub 2020 Mar 5.
This study investigated the hypoglycemic effect of the methanol extract of Shorea roxburghii leaves (SRL) in high fat diet/high fructose solution (HFDHF) and streptozotocin (STZ) induced type 2 diabetes mellitus (T2DM) in rats as well as evaluating its ameliorative potentials in altered biochemical and hematological parameters in the treated rats. T2DM was induced in Sprague Dawley (SD) rats by feeding with HFDHF for 4 weeks and administering STZ (35 mg/kg, i. p.). Diabetic rats were given SRL extract at doses of 100 and 400 mg/kg for 30 days. The food and water intake were monitored on a daily basis, while the fasting blood glucose (FBG) levels and body weight were measured weekly. Biochemical and hematological parameters as well as histopathological studies of the pancreas were also evaluated. SRL significantly decreased FBG and improved the body weight, food and water intake of treated diabetic rats. Furthermore, biochemical and hematological parameters including liver and kidney function enzymes, lipid profiles, white blood and red blood cells parameters were markedly ameliorated by SRL. Histopathological analyses of the pancreas indicated reconstitution of β-cells architecture in SRL treated rats. The results of this study suggest that SRL has antidiabetic potential and can be considered for the treatment of T2DM.
本研究旨在探讨石栗叶片甲醇提取物(SRL)在高脂饮食/高果糖溶液(HFDHF)和链脲佐菌素(STZ)诱导的 2 型糖尿病(T2DM)大鼠中的降血糖作用,并评估其对治疗大鼠生化和血液学参数改变的改善潜力。通过用 HFDHF 喂养 4 周和腹腔注射 STZ(35mg/kg),使 Sprague Dawley(SD)大鼠诱导 T2DM。糖尿病大鼠分别给予 SRL 提取物 100 和 400mg/kg 治疗 30 天。每天监测食物和水的摄入量,每周测量空腹血糖(FBG)水平和体重。还评估了生化和血液学参数以及胰腺的组织病理学研究。SRL 可显著降低 FBG,并改善治疗糖尿病大鼠的体重、食物和水摄入量。此外,SRL 显著改善了包括肝功能和肾功能酶、脂质谱、白细胞和红细胞参数在内的生化和血液学参数。胰腺的组织病理学分析表明 SRL 治疗大鼠的β细胞结构得到重建。本研究结果表明,SRL 具有抗糖尿病潜力,可考虑用于治疗 T2DM。